Human papillomavirus-related carcinomas of the sinonasal tract

American Journal of Surgical Pathology

Volumn 37, Issue 2, 2013, Pages 185-192

  Bishop, Justin A ^a   Guo, Theresa W ^b   Smith, David F ^b   Wang, Hao ^c   Ogawa, Takenori ^b   Pai, Sara I ^b,c   Westra, William H ^a,b,c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Department of Otolaryngology/Head and Neck Surgery ^*  (United States)

^c DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

adenoid cystic carcinoma; human papillomavirus; sinonasal carcinoma; sinonasal undifferentiated carcinoma; squamous cell carcinoma

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; VIRUS DNA;

ADENOID CYSTIC CARCINOMA; ADULT; AGED; ARTICLE; COMORBIDITY; FEMALE; GENETICS; HUMAN; IN SITU HYBRIDIZATION; ISOLATION AND PURIFICATION; MALE; METABOLISM; MIDDLE AGED; PAPILLOMA VIRUS; PAPILLOMAVIRUS INFECTION; PARANASAL SINUS TUMOR; PATHOLOGY; SMALL CELL CARCINOMA; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; TISSUE MICROARRAY; VIROLOGY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, ADENOID CYSTIC; CARCINOMA, SMALL CELL; COMORBIDITY; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA, VIRAL; FEMALE; HUMANS; IN SITU HYBRIDIZATION; MALE; MIDDLE AGED; NEOPLASMS, SQUAMOUS CELL; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PARANASAL SINUS NEOPLASMS; SURVIVAL RATE; TISSUE ARRAY ANALYSIS;

EID: 84872862169     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e3182698673     Document Type: Article

References (44)

1. Turner JH, Reh DD. Incidence and survival in patients with sinonasal cancer: a historical analysis of population-based data. Head Neck. 2012;34:877-885.
2. Ayiomamitis A, Parker L, Havas T. The epidemiology of malignant neoplasms of the nasal cavities, the paranasal sinuses and the middle ear in Canada. Arch Otorhinolaryngol. 1988;244:367-371.
3. Barnes L, Tse LLY, Hunt JL, et al. Tumours of the nasal cavity and paranasal sinuses: introduction. In: Barnes L, Eveson JW, Reichart P, et al, eds. World Health Organization Classification of Tumours: Pathology and Genetics of Head and neck Tumours. Lyon, France: IARC Press; 2005:12-15.
4. Demers PA, Kogevinas M, Boffetta P, et al. Wood dust and sinonasal cancer: pooled reanalysis of twelve case-control studies. Am J Ind Med. 1995;28:151-166.
5. d'Errico A, Pasian S, Baratti A, et al. A case-control study on occupational risk factors for sinonasal cancer. Occup Environ Med. 2009;66:448-455.
6. Luce D, Gerin M, Leclerc A, et al. Sinonasal cancer and occupational exposure to formaldehyde and other substances. Int J Cancer. 1993;53:224-231.
7. Luce D, Leclerc A, Begin D, et al. Sinonasal cancer and occupational exposures: a pooled analysis of 12 case-control studies. Cancer Causes Control. 2002;13:147-157.
8. Hayes RB, Kardaun JW, de Bruyn A. Tobacco use and sinonasal cancer: a case-control study. Br J Cancer. 1987;56:843-846.
9. 't Mannetje A, Kogevinas M, Luce D, et al. Sinonasal cancer, occupation, and tobacco smoking in European women and men. Am J Ind Med. 1999;36:101-107.
10. Jackson RT, Fitz-Hugh GS, Constable WC. Malignant neoplasms of the nasal cavities and paranasal sinuses: (a retrospective study). Laryngoscope. 1977;87:726-736.
11. Gillison ML, Koch WM, Capone RB, et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst. 2000;92:709-720.
12. Singhi AD, Westra WH. Comparison of human papillomavirus in situ hybridization and p16 immunohistochemistry in the detection of human papillomavirus-associated head and neck cancer based on a prospective clinical experience. Cancer. 2010;116:2166-2173.
13. Syrjanen S, Happonen RP, Virolainen E, et al. Detection of human papillomavirus (HPV) structural antigens and DNA types in inverted papillomas and squamous cell carcinomas of the nasal cavities and paranasal sinuses. Acta Otolaryngol. 1987;104:334-341.
14. Shen J, Tate JE, Crum CP, et al. Prevalence of human papillomaviruses (HPV) in benign and malignant tumors of the upper respiratory tract. Mod Pathol. 1996;9:15-20.
15. Saegusa M, Nitta H, Hashimura M, et al. Down-regulation of p27Kip1 expression is correlated with increased cell proliferation but not expression of p21waf1 and p53, and human papillomavirus infection in benign and malignant tumours of sinonasal regions. Histopathology. 1999;35:55-64.
16. Alos L, Moyano S, Nadal A, et al. Human papillomaviruses are identified in a subgroup of sinonasal squamous cell carcinomas with favorable outcome. Cancer. 2009;115:2701-2709.
17. Buchwald C, Lindeberg H, Pedersen BL, et al. Human papilloma virus and p53 expression in carcinomas associated with sinonasal papillomas: a Danish Epidemiological study 1980-1998. Laryngoscope. 2001;111:1104-1110.
18. Cheung FM, Lau TW, Cheung LK, et al. Schneiderian papillomas and carcinomas: a retrospective study with special reference to p53 and p16 tumor suppressor gene expression and association with HPV. Ear Nose Throat J. 2010;89:E5-E12.
19. El-Mofty SK, Lu DW. Prevalence of high-risk human papillomavirus DNA in nonkeratinizing (cylindrical cell) carcinoma of the sinonasal tract: a distinct clinicopathologic and molecular disease entity. Am J Surg Pathol. 2005;29:1367-1372.
20. Furuta Y, Takasu T, Asai T, et al. Detection of human papillomavirus DNA in carcinomas of the nasal cavities and paranasal sinuses by polymerase chain reaction. Cancer. 1992;69:353-357.
21. Jo VY, Mills SE, Stoler MH, et al. Papillary squamous cell carcinoma of the head and neck: frequent association with human papillomavirus infection and invasive carcinoma. Am J Surg Pathol. 2009;33:1720-1724.
22. Kashima HK, Kessis T, Hruban RH, et al. Human papillomavirus in sinonasal papillomas and squamous cell carcinoma. Laryngoscope. 1992;102:973-976.
23. Klemi PJ, Joensuu H, Siivonen L, et al. Association of DNA aneuploidy with human papillomavirus-induced malignant transformation of sinonasal transitional papillomas. Otolaryngol Head Neck Surg. 1989;100:563-567.
24. McKay SP, Gregoire L, Lonardo F, et al. Human papillomavirus (HPV) transcripts in malignant inverted papilloma are from integrated HPV DNA. Laryngoscope. 2005;115:1428-1431.
25. Mineta H, Ogino T, Amano HM, et al. Human papilloma virus (HPV) type 16 and 18 detected in head and neck squamous cell carcinoma. Anticancer Res. 1998;18:4765-4768.
26. Syrjanen KJ. HPV infections in benign and malignant sinonasal lesions. J Clin Pathol. 2003;56:174-181.
27. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Summary of data reported and evaluation. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Volume 90: Human Papillomaviruses. Lyon, France: IARC Press; 2007:465-476.
28. Serrano MF, El-Mofty SK, Gnepp DR, et al. Utility of high molecular weight cytokeratins, but not p63, in the differential diagnosis of neuroendocrine and basaloid carcinomas of the head and neck. Hum Pathol. 2008;39:591-598.
29. Emanuel P, Wang B, Wu M, et al. p63 Immunohistochemistry in the distinction of adenoid cystic carcinoma from basaloid squamous cell carcinoma. Mod Pathol. 2005;18:645-650.
30. El-Naggar AK, Westra WH. p16 expression as a surrogate marker for HPV-related oropharyngeal carcinoma: a guide for interpretative relevance and consistency. Head Neck. 2012;34:459-461.
31. Hoffmann M, Ihloff AS, Gorogh T, et al. p16(INK4a) overexpression predicts translational active human papillomavirus infection in tonsillar cancer. Int J Cancer. 2010;127:1595-1602.
32. Begum S, Cao D, Gillison M, et al. Tissue distribution of human papillomavirus 16 DNA integration in patients with tonsillar carcinoma. Clin Cancer Res. 2005;11:5694-5699.
33. Westra WH. The changing face of head and neck cancer in the 21st century: the impact of HPV on the epidemiology and pathology of oral cancer. Head Neck Pathol. 2009;3:78-81.
34. Lawson W, Schlecht NF, Brandwein-Gensler M. The role of the human papillomavirus in the pathogenesis of Schneiderian inverted papillomas: an analytic overview of the evidence. Head Neck Pathol. 2008;2:49-59.
35. Begum S, Westra WH. Basaloid squamous cell carcinoma of the head and neck is a mixed variant that can be further resolved by HPV status. Am J Surg Pathol. 2008;32:1044-1050.
36. Masand RP, El-Mofty SK, Ma XJ, et al. Adenosquamous carcinoma of the head and neck: relationship to human papillomavirus and review of the literature. Head Neck Pathol. 2011;5:108-116.
37. Bishop JA, Westra WH. Human papillomavirus-related small cell carcinoma of the oropharynx. Am J Surg Pathol. 2011;35: 1679-1684.
38. Boland JM, McPhail ED, Garcia JJ, et al. Detection of human papilloma virus and p16 expression in high-grade adenoid cystic carcinoma of the head and neck. Mod Pathol. 2012;25:529-536.
39. Adelstein DJ, Ridge JA, Gillison ML, et al. Head and neck squamous cell cancer and the human papillomavirus: summary of a National Cancer Institute State of the Science Meeting, November 9-10, 2008, Washington, DC. Head Neck. 2009;31: 1393-1422.
40. Gillison ML, D'Souza G, Westra W, et al. Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. J Natl Cancer Inst. 2008;100:407-420.
41. D'Souza G, Kreimer AR, Viscidi R, et al. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med. 2007;356:1944-1956.
42. Simard EP, Ward EM, Siegel R, et al. Cancers with increasing incidence trends in the United States: 1999 through 2008. CA Cancer J Clin. 2012 [Epub ahead of print].
43. Ang KK, Harris J, Wheeler R, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med. 2010;363:24-35.
44. Fakhry C, Westra WH, Li S, et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst. 2008;100:261-269.